UNSPSC 85521821: Supplement left subclavian vein with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left subclavian vein with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05U637Z

UNSPSC 85521821 Supplement left subclavian vein with autologous tissue substitute, percutaneous approach is a Commodity code that does not map to the state and local opportunities in the source. The recent solicitations tagged under this code—independent medical evaluations for disability retirement, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—describe administrative health services, benefits management, and clinical staffing arrangements rather than surgical procedures or vascular interventions. The code's nominal scope (a specific surgical technique involving tissue supplementation) bears no relationship to what is actually being solicited in the state and local market under this tag.

The geographic spread of these opportunities spans multiple states and jurisdictions including Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County Juvenile Probation Department), and Florida (Collier County Board of County Commissioners), but the mismatch between the code's surgical specificity and the health administrative and staffing services described in these RFPs, RFIs, and RFQ vehicles suggests a taxonomic misalignment rather than a meaningful procurement category for surgical vendors or supply chain participants in state and local government.